Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management
Aditi Kumar1, Daniel Wheatley1, Amar Puttanna2
1Russells Hall Hospital, Dudley, UK.
Clinical Medicine Insights. Gastroenterology
|June 23, 2016
Summary
Primary sclerosing cholangitis is a rare, chronic liver disease requiring careful management. This overview covers limited treatment options and essential surveillance for associated conditions.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Primary sclerosing cholangitis (PSC) is a rare, chronic, immune-mediated liver disease.
- PSC presents significant clinical challenges due to limited effective therapies and weak evidence supporting current treatments.
- Management complexities include limited endoscopic interventions and the risk of disease recurrence post-liver transplantation.
Purpose of the Study:
- To provide a comprehensive overview of primary sclerosing cholangitis.
- To focus on current therapeutic strategies for PSC management.
- To offer guidance on essential surveillance protocols for patients with PSC.
Main Methods:
- Literature review of primary sclerosing cholangitis.
- Analysis of current therapeutic options for PSC.
- Review of surveillance guidelines for associated conditions.
Main Results:
- Limited effective therapeutic options exist for primary sclerosing cholangitis.
- Endoscopic interventions are reserved for specific obstructive stricture-related cases.
- Surveillance for inflammatory bowel disorders, metabolic bone disease, and malignancy is critical.
Conclusions:
- Primary sclerosing cholangitis requires vigilant management due to its chronic and immune-mediated nature.
- Current treatment landscape for PSC is limited, necessitating careful consideration of available options.
- Proactive surveillance for associated comorbidities is paramount for optimal patient outcomes in PSC.
More Related Videos
04:03Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery
Published on: March 28, 2025
621
04:02Laparoscopic Cholecystectomy with Indocyanine Green Fluorescence: Choledochoscopic Stone Extraction and Primary Duct Suture
Published on: November 25, 2025
633
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
462
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
462
01:17Chronic Bowel Disorders: Introduction
891
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
891
01:21Inflammatory Bowel Disease V: Surgical Management
818
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
818
01:28Esophageal Varices-II: Clinical Features and Management
730
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
730
01:29Inflammatory Bowel Disease IV: Pharmacological Management
902
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
902
01:30Acute Pancreatitis II: Clinical Manifestations and Management
1.0K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.0K